# Genome-wide CRISPR screens identify the EXO1-CAF-1 pathway suppressing R-loop-associated DNA damage

**Authors:** Alexandra Nusawardhana, Anastasia Hale, Joshua Straka, Claudia M Nicolae, George-Lucian Moldovan

PMC · DOI: 10.1093/nar/gkag226 · Nucleic Acids Research · 2026-03-17

## TL;DR

This study identifies a DNA repair pathway involving EXO1 and CAF-1 that suppresses DNA damage caused by R-loops, revealing their roles in genomic stability.

## Contribution

The study reveals a novel EXO1-CAF-1 pathway for suppressing R-loop-associated DNA damage and identifies synthetic lethality between these proteins.

## Key findings

- EXO1 is critical for suppressing cisplatin-induced DNA damage in wildtype cells.
- EXO1 and CAF-1 independently suppress R-loops and work synergistically to prevent DNA damage.
- Loss of both EXO1 and CAF-1 leads to R-loop accumulation and increased DNA damage even without DNA damage treatment.

## Abstract

DNA repair is critical for cellular homeostasis under both normal conditions as well as in response to genotoxic agents such as chemotherapeutics. EXO1 is a 5′–3′ exonuclease with multiple roles in DNA biology. To better understand these roles, we employed CRISPR loss-of-function genome-wide screening to identify genes required for proliferation and cisplatin sensitivity in EXO1-deficient cells. We uncovered differential regulators of cisplatin sensitivity between wildtype (WT) and EXO1-deficient cells. By analyzing the genetic networks that these regulators belong to, we found that DNA repair was the main biological process suppressing cisplatin sensitivity in WT cells, but this was not the case in EXO1-deficient cells, indicating that EXO1 is critical for the repair of cisplatin-induced DNA damage. Moreover, synthetic lethality screens identified a genetic interaction between EXO1 and the histone chaperone CAF-1. Mechanistically, we show that EXO1 and CAF-1 are independently recruited to R-loops and participate in separate, synergistic pathway of R-loop suppression. Even in the absence of DNA damage treatment, concomitant loss of EXO1 and CAF-1 causes R-loop accumulation and increased R-loop-associated DNA damage. Our work sheds light on the critical roles of EXO1 in genomic stability.

Graphical Abstract

## Linked entities

- **Genes:** EXO1 (exonuclease 1) [NCBI Gene 9156], CHAF1B (chromatin assembly factor 1 subunit B) [NCBI Gene 8208]
- **Proteins:** EXO1 (exonuclease 1), CHAF1B (chromatin assembly factor 1 subunit B)
- **Chemicals:** cisplatin (PubChem CID 5460033)

## Full-text entities

- **Genes:** CHAF1A (chromatin assembly factor 1 subunit A) [NCBI Gene 10036] {aka CAF-1, CAF1, CAF1B, CAF1P150, P150}, PARP1 (poly(ADP-ribose) polymerase 1) [NCBI Gene 142] {aka ADPRT, ADPRT 1, ADPRT1, ARTD1, PARP, PARP-1}, HUWE1 (HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1) [NCBI Gene 10075] {aka ARF-BP1, HECTH9, HSPC272, Ib772, LASU1, MRXST}, UBE2T (ubiquitin conjugating enzyme E2 T) [NCBI Gene 29089] {aka FANCT, HSPC150, PIG50}, RNASEH1 (ribonuclease H1) [NCBI Gene 246243] {aka H1RNA, PEOB2, RNH1}, BLM (BLM RecQ like helicase) [NCBI Gene 641] {aka BS, MGRISCE1, RECQ2, RECQL2, RECQL3}, FUS (FUS RNA binding protein) [NCBI Gene 2521] {aka ALS6, ETM4, FUS1, HNRNPP2, POMP75, TLS}, PCNA (proliferating cell nuclear antigen) [NCBI Gene 5111] {aka ATLD2}, FANCA (FA complementation group A) [NCBI Gene 2175] {aka FA, FA-H, FA1, FAA, FACA, FAH}, FANCL (FA complementation group L) [NCBI Gene 55120] {aka FAAP43, PHF9, POG}, FANCB (FA complementation group B) [NCBI Gene 2187] {aka FA2, FAAP90, FAAP95, FAB, FACB}, H4C2 (H4 clustered histone 2) [NCBI Gene 8366] {aka H4/I, H4FI, HIST1H4B}, RAD18 (RAD18 E3 ubiquitin protein ligase) [NCBI Gene 56852] {aka RNF73}, EXO1 (exonuclease 1) [NCBI Gene 9156] {aka HEX1, hExoI}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, BRCA1 (BRCA1 DNA repair associated) [NCBI Gene 672] {aka BRCAI, BRCC1, BROVCA1, FANCS, IRIS, PNCA4}, CHD4 (chromodomain helicase DNA binding protein 4) [NCBI Gene 1108] {aka CHD-4, Mi-2b, Mi2-BETA, SIHIWES}, RAD54L (RAD54 like) [NCBI Gene 8438] {aka HR54, RAD54A, hHR54, hRAD54}, PRIMPOL (primase and DNA directed polymerase) [NCBI Gene 201973] {aka CCDC111, MYP22, Primpol1}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, FANCM (FA complementation group M) [NCBI Gene 57697] {aka FAAP250, KIAA1596, POF15, SPGF28}, RAD51B (RAD51 paralog B) [NCBI Gene 5890] {aka R51H2, RAD51L1, REC2}, HLTF (helicase like transcription factor) [NCBI Gene 6596] {aka HIP116, HIP116A, HLTF1, RNF80, SMARCA3, SNF2L3}, FANCF (FA complementation group F) [NCBI Gene 2188] {aka FAF}, SETX (senataxin) [NCBI Gene 23064] {aka ALS4, AOA2, SCAN2, SCAR1, STEX, Sen1}, KAT2B (lysine acetyltransferase 2B) [NCBI Gene 8850] {aka CAF, P/CAF, PCAF}
- **Diseases:** EXO1KO#3 (MESH:C537153), intestine dysfunction (MESH:D007410), heart and kidney dysfunction (MESH:D007674), EXO1KO#1 (MESH:C538557), infection (MESH:D007239), gastrointestinal distress (MESH:D012128), Cancer (MESH:D009369), weight loss (MESH:D015431), FA (MESH:D005199)
- **Chemicals:** crystal violet (MESH:D005840), Lipofectamine (MESH:C086724), BioRender (-), Duolink (MESH:C431350), Cisplatin (MESH:D002945), sodium dodecyl sulphate (MESH:D012967), paraformaldehyde (MESH:C003043), platinum (MESH:D010984), acetic acid (MESH:D019342), methanol (MESH:D000432), PBS (MESH:D007854), puromycin (MESH:D011691), guanines (MESH:D006147), BrdU (MESH:D001973), carboplatin (MESH:D016190)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** T2A, D173A
- **Cell lines:** HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030), S9.6 — Mus musculus (Mouse), Hybridoma (CVCL_G144), EXO1KO#3 — Homo sapiens (Human), Prostate carcinoma, Cancer cell line (CVCL_C6ZQ)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12993451/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12993451/full.md

## References

58 references — full list in the complete paper: https://tomesphere.com/paper/PMC12993451/full.md

---
Source: https://tomesphere.com/paper/PMC12993451